On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now


SRAX Inc.’s (NASDAQ: SRAX) Sequire Platform Proof Positive of Company’s Relevance in Today’s Changing Markets

  • Sequire now available as free mobile app, gives SRAX clients benefits of entire platform
  • With mobile app, companies can monitor behaviors, contributions of investors anytime and anywhere
  • Since its release, Sequire has surpassed 500,000 active investors and traders, sales have exceeded $2.5 million

In a world transformed by a worldwide epidemic, companies that offer flexible services and options that support new ways of doing business appear to be ideally positioned for success. With Sequire, SRAX Inc. (NASDAQ: SRAX) has honed in on precisely what today’s public businesses are looking for. The proprietary investor intelligence and communications platform provides an intuitive, virtual method for companies to monitor retail and institutional investors as well as activate media campaigns to engage existing investors while attracting new ones — and the newest additions to the platform illustrate how effective SRAX is at adapting to a world that is moving online.

Originally available as a computer app, Sequire is now also available as a mobile app and can be downloaded for free on the App Store and Google Play (http://ibn.fm/gwBNW), allowing SRAX clients to enjoy all the benefits of the entire platform regardless of where they are. With Sequire, businesses can unlock stock buyers’ behaviors and trends; manage and monitor return on investment from investor relations programs and corporate communications firms; and engage current and potential stock buyers at their trading desks, investor events or at home on both desktop or mobile.

“We are thrilled to launch the Sequire mobile app enabling our clients to now monitor their investors’ behaviors and their contributions anytime and anywhere,” said SRAX CEO and founder Christopher Miglino. “We’ll also be launching more exciting mobile features in the next few months, so stay tuned.”

Clear evidence of SRAX’s ability to recognize what today’s market demands is the success of the platform. Since its release, Sequire has surpassed 500,000 active investors and traders while sales have exceeded $2.5 million in Q2 2020 (http://ibn.fm/5RIyk), In addition, the addition of Sequire’s relatively new Virtual Roadshow, which allows companies to host one-on-one or one-to-many video and audio meetings (http://ibn.fm/jnQSx), shows how nimble and relevant the company can be.

With virtual communication deemed an essential component of today’s business operations, the Virtual Roadshow provides a safe, effective way for companies to present their stories to new shareholders, offer quarterly and annual updates to existing shareholders, and reach out to a wide range of individuals and entities.

“The ecosystem for investor events will be changed forever after the current environment,” said Miglino. “Investors and issuers will no longer need to meet in person. New technologies are providing the tools that issuers need to meet with current and prospective investors. The organizers of these events are the cornerstone of the industry and our system will allow for them to create their own events on the platform and profit from letting issuers invite investors from proprietary lists to the issuers roadshows. Video is the future of investor communication, and we are thrilled to add this feature to the platform.”

SRAX’s technology unlocks data for brands in the CPG, investor relations, luxury, and lifestyle verticals. Through its various platforms, SRAX is monetizing its data sets and growing multiple recurring revenue streams. In addition to BIGtoken, the company offers Sequire, a premier platform for investor intelligence and communication. Through Sequire, public companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels.

For more information, visit the company’s website at www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

From Our Blog

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is “One to Watch”

September 25, 2020

CNS Pharmaceuticals’ lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and currently incurable form of brain cancer. In a Phase I clinical trial of Berubicin in malignant brain tumors, 44% of patients experienced a statistically significant improvement in clinical benefit. In preclinical studies, the company’s second drug candidate, […]

Rotate your device 90° to view site.